Seborrheic Dermatitis on the Face Clinical Trial
Official title:
A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face
This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.
To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face ;